Canopy Growth: Consensus Estimates For Q4 2021

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal fourth quarter financials before market open on June 1st.

Analysts have a consensus C$37.76 12-month price target on the company, via a total of 15 analysts, with one analyst having a strong buy rating, and two analysts have a buy rating. Eight analysts have a hold rating and four analysts have a strong sell rating. The street high comes from Desjardins with a C$55 price target, and the lowest target comes from Stifel GMP with a C$21 price target.

15 analysts have revenue estimates for the fourth quarter. The mean between all 15 is C$151.77 million; this number has been revised slightly downwards from C$158.68 million at the start of the year. The street high is C$169.11 million while the lowest sits at C$140 million.

Five analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 26.23%, with this number being revised slightly downwards from 28% at the start of the year. Street high goes to Stifel-GMP with a 28% estimate and the lowest sits at 18%.

Onto EBITDA estimates, there are currently 13 analysts who have fourth quarter EBITDA estimates. The mean is currently (C$64.73) million, with this number being lower at the start of the year. Street high goes to Oppenheimer with a (C$41.41) million EBITDA estimate and the lowest being a (C$84.53) million estimate.


Information for this briefing was found via Sedar and Canopy Growth. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM

PopReach Receives Upgraded Price Target from Canaccord Amid $5M Investment from Alibaba Investment Arm

On Thursday, PopReach (TSXV: POPR) announced a $5.0 million investment from eWTP Tech Innovation Fund...

Sunday, October 18, 2020, 12:48:00 PM

BMO Upgrades Cineplex Price Target To $7.00, Rating To Market Perform

On Friday, Cineplex Inc (TSX: CGX) reported their third quarter results. Cineplex’s revenue was $61...

Monday, November 16, 2020, 03:36:00 PM

Haywood Initiates On Bragg Gaming With $3.00 Price Target

Earlier this week, Haywood Capital Markets initiated coverage on Bragg Gaming (TSX: BRAG) with a...

Wednesday, April 28, 2021, 03:21:00 PM

BofA: Shifts In Public Perception Driving Change [In Cannabis Legislation] Today

Yesterday, BofA Securities released a cannabis primer that largely focused on Canadian operators, such as...

Friday, December 4, 2020, 12:16:53 PM